We are live on
!
Find out more
BH
Broadfin Holdings Portfolio holdings
AUM
$23.7M
This Fund
S&P 500
This Quarter
Est. Return
-11.45%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$23.5M
AUM Growth
–
Cap. Flow
+$22.4M
Cap. Flow
% of AUM
95.3%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
1
New
1
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AngioDynamics
ANGO
|
+$22.4M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
AngioDynamics
ANGO
$652M
| $23.5M | 100% |
+2,069,333
| New | +$22.4M |
|
Similar funds
CC
PCM
VEPM
BC
DPRC
IW
HIIL
SCM
Broadfin Holdings's Q1 2026 Portfolio in Review
Q1 2026 is the first quarter with a 13F filing on record for Broadfin Holdings, which disclosed 1 position worth $23.5M. Its ten largest holdings account for 100% of the portfolio.
Its largest position is AngioDynamics: 2,069,333 shares worth $23.5M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets.
- Broadfin Holdings's largest Q1 2026 buy was AngioDynamics: 2,069,333 shares worth $23.5M.
- Broadfin Holdings's ten largest holdings make up 100% of its $23.5M portfolio in Q1 2026.
- Broadfin Holdings disclosed 1 position in Q1 2026, its first 13F filing on record.
Based on Broadfin Holdings's 13F filing for Q1 2026, filed 15 May 2026.